20.34
price down icon0.39%   -0.08
after-market Dopo l'orario di chiusura: 20.34
loading
Precedente Chiudi:
$20.42
Aprire:
$20.25
Volume 24 ore:
353.25K
Relative Volume:
0.83
Capitalizzazione di mercato:
$520.86M
Reddito:
$219.79M
Utile/perdita netta:
$-57.47M
Rapporto P/E:
-9.4605
EPS:
-2.15
Flusso di cassa netto:
$-19.25M
1 W Prestazione:
+6.16%
1M Prestazione:
+27.36%
6M Prestazione:
-23.68%
1 anno Prestazione:
-4.01%
Intervallo 1D:
Value
$20.01
$20.58
Intervallo di 1 settimana:
Value
$18.81
$20.63
Portata 52W:
Value
$15.45
$35.84

Castle Biosciences Inc Stock (CSTL) Company Profile

Name
Nome
Castle Biosciences Inc
Name
Telefono
866-788-9007
Name
Indirizzo
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Name
Dipendente
784
Name
Cinguettio
@castlebio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
CSTL's Discussions on Twitter

Confronta CSTL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
CSTL
Castle Biosciences Inc
20.34 520.86M 219.79M -57.47M -19.25M -2.15
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.47 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
201.10 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.65 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.45 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
162.61 27.64B 15.50B 1.33B 2.16B 7.34

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-12-14 Iniziato Guggenheim Buy
2023-01-05 Iniziato Scotiabank Sector Outperform
2022-01-07 Iniziato Stephens Overweight
2021-04-30 Iniziato Lake Street Buy
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2019-12-27 Reiterato Canaccord Genuity Buy
2019-08-19 Iniziato BTIG Research Buy
2019-08-19 Iniziato Canaccord Genuity Buy
2019-08-19 Iniziato Robert W. Baird Outperform
2019-08-19 Iniziato SVB Leerink Outperform
Mostra tutto

Castle Biosciences Inc Borsa (CSTL) Ultime notizie

pulisher
Jun 18, 2025

Castle Biosciences partners with SciBase for diagnostic tests - MSN

Jun 18, 2025
pulisher
Jun 17, 2025

Castle Biosciences Inc (CSTL) Stock Price Down 4.54% on Jun 17 - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Castle Biosciences, SciBase Partner to Develop Predictive Tests for Skin Conditions - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase for diagnostic tests (CSTL) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences enters collaboration, license agreement with Scibase to develop diagnostic tests for dermatologic diseases - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement wi - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences (CSTL) Partners with SciBase for Dermatology Advancements | CSTL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase to develop atopic dermatitis test - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase signs license agreement with Castle Biosciences to develop dermatology diagnostic tests - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

New Diagnostic Test Could Predict Atopic Dermatitis Flares Before Symptoms Appear - Stock Titan

Jun 16, 2025
pulisher
Jun 15, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - Barchart.com

Jun 14, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention | CSTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion ... - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Acquires New Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Squarepoint Ops LLC Lowers Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire

Jun 04, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Makes New $230,000 Investment in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Castle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025 - Insider Monkey

May 30, 2025
pulisher
May 29, 2025

Castle Biosciences Presents Innovative Research on Melanoma Risk Stratification at ASCO 2025 - Nasdaq

May 29, 2025
pulisher
May 29, 2025

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's - GlobeNewswire

May 29, 2025
pulisher
May 27, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 27, 2025
pulisher
May 27, 2025

Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 27, 2025

Nuveen Asset Management LLC Has $12.41 Million Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 24, 2025

Deutsche Bank AG Buys 7,495 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 24, 2025

Bank of America Corp DE Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote By Investing.com - Investing.com India

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences Holds Annual Stockholders Meeting - TipRanks

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote - Investing.com

May 23, 2025
pulisher
May 23, 2025

Some Confidence Is Lacking In Castle Biosciences, Inc. (NASDAQ:CSTL) As Shares Slide 28% - simplywall.st

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences stock hits 52-week low at $15.66 By Investing.com - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Scotiabank Issues Pessimistic Forecast for Castle Biosciences (NASDAQ:CSTL) Stock Price - Defense World

May 23, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Price Target Revised by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healt - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences Executive Team Reveals Strategic Updates at Jefferies Healthcare Conference - Stock Titan

May 21, 2025
pulisher
May 21, 2025

90,563 Shares in Castle Biosciences, Inc. (NASDAQ:CSTL) Purchased by D. E. Shaw & Co. Inc. - Defense World

May 21, 2025
pulisher
May 21, 2025

Ameriprise Financial Inc. Has $8.42 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 21, 2025
pulisher
May 19, 2025

Northern Trust Corp Boosts Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Jane Street Group LLC Reduces Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025

Castle Biosciences Inc Azioni (CSTL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Castle Biosciences Inc Azioni (CSTL) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 21 '25
Sale
21.52
4,408
94,851
4,275
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 21 '25
Sale
21.52
1,236
26,596
74,627
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 09 '25
Sale
20.22
3,647
73,739
4,440
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 09 '25
Sale
20.22
1,023
20,684
75,863
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 08 '25
Sale
20.03
761
15,243
4,577
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 08 '25
Sale
20.03
213
4,266
76,886
diagnostics_research DGX
$179.33
price down icon 0.17%
diagnostics_research WAT
$357.04
price up icon 2.29%
diagnostics_research LH
$264.26
price up icon 0.67%
$160.72
price down icon 4.87%
diagnostics_research MTD
$1,205.29
price up icon 2.60%
diagnostics_research IQV
$162.61
price up icon 3.19%
Capitalizzazione:     |  Volume (24 ore):